OPKO Health, Inc. Operating Expenses
OPKO Health, Inc. (OPK) reported Operating Expenses of $186.77 million for the 3-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-02-26
- OPKO Health, Inc. operating expenses for the quarter ending 2025-12-31 was $186.77M, a 13.84% decline year-over-year.
- OPKO Health, Inc. operating expenses for the quarter ending 2025-09-30 was $103.61M, a 35.00% decline year-over-year.
- OPKO Health, Inc. operating expenses for the quarter ending 2025-06-30 was $216.79M, a 11.10% decline year-over-year.
- OPKO Health, Inc. operating expenses for the quarter ending 2025-03-31 was $217.12M, a 11.44% decline year-over-year.
- OPKO Health, Inc. operating expenses for fiscal 2023 was $1.02B, a 17.06% decline from fiscal 2022.
- OPKO Health, Inc. operating expenses for fiscal 2022 was $1.23B, a 29.93% decline from fiscal 2021.
- OPKO Health, Inc. operating expenses for fiscal 2021 was $1.76B, a 27.46% increase from fiscal 2020.
- OPKO Health, Inc. operating expenses for fiscal 2020 was $1.38B, a 17.15% increase from fiscal 2019.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $186.77M 10-K · filed 2026-02-26 | $290.38M derived: sum of 2 quarters · filed 2026-02-26 | $507.17M derived: sum of 3 quarters · filed 2026-02-26 | $724.29M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2025-09-30 | $103.61M 10-K · filed 2026-02-26 | $320.40M derived: sum of 2 quarters · filed 2026-02-26 | $537.52M derived: sum of 3 quarters · filed 2026-02-26 | $754.30M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2025-06-30 | $216.79M 10-K · filed 2026-02-26 | $433.91M derived: sum of 2 quarters · filed 2026-02-26 | $650.68M derived: sum of 3 quarters · filed 2026-02-26 | $810.10M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2025-03-31 | $217.12M 10-K · filed 2026-02-26 | $433.90M derived: sum of 2 quarters · filed 2026-02-26 | $593.31M derived: sum of 3 quarters · filed 2026-02-26 | $837.17M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-12-31 | $216.78M 10-K · filed 2026-02-26 | $376.19M derived: sum of 2 quarters · filed 2026-02-26 | $620.05M derived: sum of 3 quarters · filed 2026-02-26 | $865.21M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-09-30 | $159.42M 10-K · filed 2026-02-26 | $403.27M derived: sum of 2 quarters · filed 2026-02-26 | $648.43M 10-Q · filed 2024-11-07 | $899.38M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | $243.86M 10-K · filed 2026-02-26 | $489.01M 10-Q · filed 2024-08-07 | $739.96M derived: sum of 3 quarters · filed 2026-02-26 | $982.97M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | $245.16M 10-K · filed 2026-02-26 | $496.11M derived: sum of 2 quarters · filed 2026-02-26 | $739.11M derived: sum of 3 quarters · filed 2026-02-26 | $997.50M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | $250.95M 10-K · filed 2025-03-03 | $493.95M derived: sum of 2 quarters · filed 2025-03-03 | $752.34M derived: sum of 3 quarters · filed 2025-03-03 | $1.02B 10-K · filed 2024-03-01 | ||||
| 2023-09-30 | $243.00M 10-K · filed 2025-03-03 | $501.39M derived: sum of 2 quarters · filed 2025-03-03 | $769.57M 10-Q · filed 2024-11-07 | $1.01B derived: sum of 4 quarters · filed 2025-03-03 | ||||
| 2023-06-30 | $258.39M 10-K · filed 2025-03-03 | $526.56M 10-Q · filed 2024-08-07 | $767.17M derived: sum of 3 quarters · filed 2025-03-03 | $1.03B derived: sum of 4 quarters · filed 2025-03-03 | ||||
| 2023-03-31 | $268.17M 10-K · filed 2025-03-03 | $508.78M derived: sum of 2 quarters · filed 2025-03-03 | $776.35M derived: sum of 3 quarters · filed 2025-03-03 | $1.10B derived: sum of 4 quarters · filed 2025-03-03 | ||||
| 2022-12-31 | $240.61M 10-K · filed 2024-03-01 | $508.17M derived: sum of 2 quarters · filed 2024-03-01 | $828.81M derived: sum of 3 quarters · filed 2024-03-01 | $1.23B 10-K · filed 2024-03-01 | ||||
| 2022-09-30 | $267.56M 10-K · filed 2024-03-01 | $588.20M derived: sum of 2 quarters · filed 2024-03-01 | $989.84M 10-Q · filed 2023-11-06 | $1.45B derived: sum of 4 quarters · filed 2024-03-01 | ||||
| 2022-06-30 | $320.63M 10-K · filed 2024-03-01 | $722.27M 10-Q · filed 2023-08-03 | $1.19B derived: sum of 3 quarters · filed 2024-03-01 | $1.53B derived: sum of 4 quarters · filed 2024-03-01 | ||||
| 2022-03-31 | $401.64M 10-K · filed 2024-03-01 | $866.06M derived: sum of 2 quarters · filed 2024-03-01 | $1.21B derived: sum of 3 quarters · filed 2024-03-01 | $1.65B derived: sum of 4 quarters · filed 2024-03-01 | ||||
| 2021-12-31 | $464.42M 10-K · filed 2023-02-27 | $812.40M derived: sum of 2 quarters · filed 2023-02-27 | $1.25B derived: sum of 3 quarters · filed 2023-02-27 | $1.76B 10-K · filed 2024-03-01 | ||||
| 2021-09-30 | $347.99M 10-K · filed 2023-02-27 | $784.82M derived: sum of 2 quarters · filed 2023-02-27 | $1.29B 10-Q · filed 2022-11-08 | $1.74B derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2021-06-30 | $436.84M 10-K · filed 2023-02-27 | $943.57M 10-Q · filed 2022-08-04 | $1.39B derived: sum of 3 quarters · filed 2023-02-27 | $1.80B derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2021-03-31 | $506.73M 10-K · filed 2023-02-27 | $952.05M derived: sum of 2 quarters · filed 2023-02-27 | $1.36B derived: sum of 3 quarters · filed 2023-02-27 | $1.63B derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2020-12-31 | $445.32M 10-K · filed 2022-03-01 | $851.44M derived: sum of 2 quarters · filed 2022-03-01 | $1.13B derived: sum of 3 quarters · filed 2022-03-01 | $1.38B 10-K · filed 2023-02-27 | ||||
| 2020-09-30 | $406.13M 10-K · filed 2022-03-01 | $680.15M derived: sum of 2 quarters · filed 2022-03-01 | $932.38M 10-Q · filed 2021-10-28 | $1.27B derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-06-30 | $274.03M 10-K · filed 2022-03-01 | $526.25M 10-Q · filed 2021-07-29 | $863.06M derived: sum of 3 quarters · filed 2022-03-01 | $1.13B derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-03-31 | $252.23M 10-K · filed 2022-03-01 | $589.03M derived: sum of 2 quarters · filed 2022-03-01 | $856.82M derived: sum of 3 quarters · filed 2022-03-01 | $1.13B derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2019-12-31 | $336.81M 10-K · filed 2021-02-18 | $604.59M derived: sum of 2 quarters · filed 2021-02-18 | $878.22M derived: sum of 3 quarters · filed 2021-02-18 | $1.18B 10-K · filed 2022-03-01 | ||||
| 2019-09-30 | $267.78M 10-K · filed 2021-02-18 | $541.41M derived: sum of 2 quarters · filed 2021-02-18 | $839.18M 10-Q · filed 2020-10-29 | $1.15B derived: sum of 4 quarters · filed 2021-02-18 | ||||
| 2019-06-30 | $273.63M 10-K · filed 2021-02-18 | $571.40M 10-Q · filed 2020-07-31 | $883.26M derived: sum of 3 quarters · filed 2021-02-18 | $1.17B derived: sum of 4 quarters · filed 2021-02-18 | ||||
| 2019-03-31 | $297.77M 10-K · filed 2021-02-18 | $609.63M derived: sum of 2 quarters · filed 2021-02-18 | $892.91M derived: sum of 3 quarters · filed 2021-02-18 | $1.16B derived: sum of 4 quarters · filed 2021-02-18 | ||||
| 2018-12-31 | $311.87M 10-K · filed 2020-03-02 | $595.14M derived: sum of 2 quarters · filed 2020-03-02 | $863.94M derived: sum of 3 quarters · filed 2020-03-02 | $1.16B 10-K · filed 2021-02-18 | ||||
| 2018-09-30 | $283.28M 10-K · filed 2020-03-02 | $552.07M derived: sum of 2 quarters · filed 2020-03-02 | $849.60M 10-Q · filed 2019-11-05 | $1.17B derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2018-06-30 | $268.79M 10-K · filed 2020-03-02 | $566.32M 10-Q · filed 2019-08-07 | $884.93M derived: sum of 3 quarters · filed 2020-03-02 | $1.18B derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2018-03-31 | $297.52M 10-K · filed 2020-03-02 | $616.14M derived: sum of 2 quarters · filed 2020-03-02 | $909.94M derived: sum of 3 quarters · filed 2020-03-02 | $1.23B derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2017-12-31 | $318.61M 10-K · filed 2019-03-01 | $347.32M 10-K · filed 2018-03-01 | $612.42M derived: sum of 2 quarters · filed 2019-03-01 | $930.85M derived: sum of 3 quarters · filed 2019-03-01 | $1.24B 10-K · filed 2020-03-02 | $1.35B 10-K · filed 2018-03-01 | ||
| 2017-09-30 | $293.81M 10-K · filed 2019-03-01 | $321.79M 10-Q · filed 2017-11-08 | $612.24M derived: sum of 2 quarters · filed 2019-03-01 | $923.83M 10-Q · filed 2018-11-09 | $1.00B 10-Q · filed 2017-11-08 | $1.23B derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2017-06-30 | $318.43M 10-K · filed 2019-03-01 | $340.66M 10-Q · filed 2017-08-08 | $630.03M 10-Q · filed 2018-08-07 | $678.46M 10-Q · filed 2017-08-08 | $935.45M derived: sum of 3 quarters · filed 2019-03-01 | $1.24B derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2017-03-31 | $311.60M 10-K · filed 2019-03-01 | $337.80M 10-Q · filed 2017-05-10 | $617.01M derived: sum of 2 quarters · filed 2019-03-01 | $917.23M derived: sum of 3 quarters · filed 2019-03-01 | $1.23B derived: sum of 4 quarters · filed 2019-03-01 | |||
| 2016-12-31 | $305.42M 8-K · filed 2019-01-29 | $325.89M 10-K · filed 2017-03-01 | $605.63M derived: sum of 2 quarters · filed 2019-01-29 | $914.31M derived: sum of 3 quarters · filed 2019-01-29 | $1.21B 10-K · filed 2019-03-01 | $1.29B 10-K · filed 2017-03-01 | ||
| 2016-09-30 | $300.22M 8-K · filed 2019-01-29 | $321.66M 10-Q · filed 2016-11-07 | $608.89M derived: sum of 2 quarters · filed 2019-01-29 | $969.05M 10-Q · filed 2017-11-08 | $1.19B derived: sum of 4 quarters · filed 2019-01-29 | |||
| 2016-06-30 | $308.68M 8-K · filed 2019-01-29 | $328.83M 10-Q · filed 2016-08-08 | $647.39M 10-Q · filed 2017-08-08 | $892.54M derived: sum of 3 quarters · filed 2019-01-29 | $1.04B derived: sum of 4 quarters · filed 2019-01-29 | |||
| 2016-03-31 | $299.73M 8-K · filed 2019-01-29 | $318.56M 10-Q · filed 2016-05-09 | $583.86M derived: sum of 2 quarters · filed 2019-01-29 | $735.12M derived: sum of 3 quarters · filed 2019-01-29 | $802.96M derived: sum of 4 quarters · filed 2019-01-29 | |||
| 2015-12-31 | $284.13M 10-K · filed 2017-03-01 | $435.38M derived: sum of 2 quarters · filed 2017-03-01 | $503.22M derived: sum of 3 quarters · filed 2017-03-01 | $568.10M 8-K · filed 2019-01-29 | $590.22M 10-K · filed 2016-02-29 | |||
| 2015-09-30 | $151.26M 10-K · filed 2017-03-01 | $219.09M derived: sum of 2 quarters · filed 2017-03-01 | $306.09M 10-Q · filed 2016-11-07 | $364.08M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-06-30 | $67.84M 10-K · filed 2017-03-01 | $154.84M 10-Q · filed 2016-08-08 | $212.82M derived: sum of 3 quarters · filed 2017-03-01 | $280.80M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-03-31 | $87.00M 10-K · filed 2017-03-01 | $144.99M derived: sum of 2 quarters · filed 2017-03-01 | $212.96M derived: sum of 3 quarters · filed 2017-03-01 | $271.39M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2014-12-31 | $57.99M 10-K · filed 2016-02-29 | $125.96M derived: sum of 2 quarters · filed 2016-02-29 | $184.39M derived: sum of 3 quarters · filed 2016-02-29 | $236.94M 10-K · filed 2017-03-01 | ||||
| 2014-09-30 | $67.97M 10-K · filed 2016-02-29 | $126.40M derived: sum of 2 quarters · filed 2016-02-29 | $178.95M 10-Q · filed 2015-11-09 | $235.51M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-30 | $58.43M 10-K · filed 2016-02-29 | $58.43M 10-Q · filed 2014-08-11 | $110.98M 10-Q · filed 2015-08-05 | $167.54M derived: sum of 3 quarters · filed 2016-02-29 | $207.19M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-03-31 | $52.55M 10-K · filed 2016-02-29 | $52.55M 10-Q · filed 2014-05-09 | $109.11M derived: sum of 2 quarters · filed 2016-02-29 | $148.76M derived: sum of 3 quarters · filed 2016-02-29 | $190.56M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2013-12-31 | $56.56M 10-K · filed 2015-02-27 | $96.21M derived: sum of 2 quarters · filed 2015-02-27 | $138.01M derived: sum of 3 quarters · filed 2015-02-27 | $176.16M 10-K · filed 2016-02-29 | ||||
| 2013-09-30 | $39.65M 10-K · filed 2015-02-27 | $39.65M 10-Q · filed 2013-11-12 | $81.45M derived: sum of 2 quarters · filed 2015-02-27 | $119.60M 10-Q · filed 2014-11-07 | $145.58M derived: sum of 4 quarters · filed 2015-02-27 | |||
| 2013-06-30 | $41.80M 10-K · filed 2015-02-27 | $41.80M 10-Q · filed 2013-08-09 | $79.95M 10-Q · filed 2014-08-11 | $105.93M derived: sum of 3 quarters · filed 2015-02-27 | $127.09M derived: sum of 4 quarters · filed 2015-02-27 | |||
| 2013-03-31 | $38.15M 10-K · filed 2015-02-27 | $26.39M 10-Q · filed 2013-05-10 | $64.12M derived: sum of 2 quarters · filed 2015-02-27 | $85.29M derived: sum of 3 quarters · filed 2015-02-27 | $104.84M derived: sum of 4 quarters · filed 2015-02-27 | |||
| 2012-12-31 | $25.97M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $47.14M derived: sum of 2 quarters · filed 2015-02-27 | $66.69M derived: sum of 3 quarters · filed 2015-02-27 | $84.31M 10-K · filed 2015-02-27 | $56.44M 10-K · filed 2013-03-18 | |||
| 2012-09-30 | $21.16M 10-Q · filed 2013-11-12 | $13.68M 10-Q · filed 2012-11-09 | $40.72M derived: sum of 2 quarters · filed 2013-11-12 | $58.34M 10-Q · filed 2013-11-12 | $39.31M 10-Q · filed 2012-11-09 | $80.71M derived: sum of 4 quarters · filed 2014-03-03 | ||
| 2012-06-30 | $19.55M 10-Q · filed 2013-08-09 | $13.00M 10-Q · filed 2012-08-09 | $37.18M 10-Q · filed 2013-08-09 | $25.64M 10-Q · filed 2012-08-09 | $59.54M derived: sum of 3 quarters · filed 2014-03-03 | $68.14M derived: sum of 4 quarters · filed 2014-03-03 | ||
| 2012-03-31 | $12.64M 10-Q · filed 2013-05-10 | $39.99M derived: sum of 2 quarters · filed 2014-03-03 | $48.59M derived: sum of 3 quarters · filed 2014-03-03 | $56.90M derived: sum of 4 quarters · filed 2014-03-03 | ||||
| 2011-12-31 | $27.35M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $35.95M derived: sum of 2 quarters · filed 2014-03-03 | $44.26M derived: sum of 3 quarters · filed 2014-03-03 | $51.17M 10-K · filed 2014-03-03 | $33.92M 10-K · filed 2012-03-15 | |||
| 2011-09-30 | $8.59M 10-Q · filed 2012-11-09 | $16.91M derived: sum of 2 quarters · filed 2012-08-09 | $23.81M 10-Q · filed 2012-11-09 | $31.96M derived: sum of 4 quarters · filed 2013-03-18 | ||||
| 2011-06-30 | $8.31M 10-Q · filed 2012-08-09 | $9.09M 10-Q · filed 2011-08-08 | $15.22M 10-Q · filed 2012-08-09 | $17.20M 10-Q · filed 2011-08-08 | $23.36M derived: sum of 3 quarters · filed 2013-03-18 | $29.91M derived: sum of 4 quarters · filed 2013-03-18 | ||
| 2011-03-31 | $6.91M 10-Q · filed 2012-05-10 | $15.05M derived: sum of 2 quarters · filed 2013-03-18 | $21.60M derived: sum of 3 quarters · filed 2013-03-18 | $29.73M derived: sum of 4 quarters · filed 2013-03-18 | ||||
| 2010-12-31 | $8.14M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $14.69M derived: sum of 2 quarters · filed 2013-03-18 | $22.82M derived: sum of 3 quarters · filed 2013-03-18 | $26.14M 10-K · filed 2013-03-18 | ||||
| 2010-09-30 | $6.55M 10-Q · filed 2011-11-09 | $14.68M derived: sum of 2 quarters · filed 2011-11-09 | $17.99M 10-Q · filed 2011-11-09 | |||||
| 2010-06-30 | $8.13M 10-Q · filed 2011-08-08 | $14.59M 10-Q · filed 2011-08-08 | ||||||
| 2009-12-31 | $23.69M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |